![James Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Brady
Director/Board Member at
XERIS BIOPHARMA HOLDINGS, INC.
Net worth: 698 291 $ as of 30/05/2026
Profile
James Brady is an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. since 2025.
Former roles include Director at Panavance Therapeutics, Inc. from 2021 to 2025, Independent Non-Executive Director at Verona Pharma Ltd. from 2022 to 2025, Chief Financial Officer at MedImmune Ltd. from 2013 to 2018, and Chief Audit Executive at AstraZeneca PLC from 2009 to 2012.
Education includes an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2026 | 113,359 ( 0.07% ) | 698 291 $ | 30/05/2026 |
James Brady active positions
| Companies | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 27/03/2025 |
Former positions of James Brady
| Companies | Position | End |
|---|---|---|
| VERONA PHARMA PLC | Director/Board Member | 06/10/2025 |
Panavance Therapeutics, Inc.
 Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Director/Board Member | 31/01/2025 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Director of Finance/CFO | 31/12/2017 |
| ASTRAZENECA PLC | Comptroller/Controller/Auditor | 31/12/2011 |
Training of James Brady
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
St. Joseph University
 St. Joseph University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Panavance Therapeutics, Inc.
Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
- Stock Market
- Insiders
- James Brady
